4-Aryl-Substituted 2,5-Dimethoxyphenethylamines: Synthesis and Serotonin 5-HT2A Receptor Affinities

被引:9
作者
Trachsel, Daniel
Nichols, David E. [1 ]
Kidd, Stephanie [1 ]
Hadorn, Marcel [2 ]
Baumberger, Franz [2 ]
机构
[1] Purdue Univ, Sch Pharm & Pharmaceut Sci, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA
[2] Fachbereich Chem, Berner Fachhsch, CH-3400 Burgdorf, Switzerland
关键词
PHOSPHOLIPASE-C; BINDING; HALLUCINOGENS; AGONISTS; DERIVATIVES; ANALOGS; POTENT; 4-NITROPHENYLTRIFLATE; PHENYLALKYLAMINES; PHENETHYLAMINES;
D O I
10.1002/cbdv.200800235
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of novel ligands for the serotonin 5-HT2A/C receptor subtype bearing the 2-phenylethylamine pharmacophore was synthesized and assayed for its 5-HT2A receptor binding affinity. As the 4'-aryl-substituted 2-(2,5-dimethoxyphenyl)ethylamines were previously unknown, an initial series of twelve compounds was chosen to obtain initial insight into their structure-activity relationships. The 4'-aryl moiety was introduced in moderate-to-high yield by a Pd-catalyzed Suzuki reaction of twelve arylboronic acids with N-Boc-protected 2-(2,5-dimethoxy-4-iodophenyl)ethylamine (8). N-Boc Deprotection then afforded the novel 2-phenylethylamines 5a-5l. Additionally, biphenyl compound 6 lacking the 5'-MeO substituent was prepared, starting from 2-methoxy-4-hydroxybenzaldehyde. Except for 51, all of the compounds proved to be antagonists with generally low affinity at the rat 5-HT2A receptor. Substituents are generally not well tolerated on the 4'-aryl moiety, except in the 4 ''-position. Indeed, the relatively high affinity of the 4 ''-butyl-, 4 ''-phenyl-, and 4'-naphthyl-substituted compounds 5i, 5k, and 5e, respectively (K-i=32, 33, and 41nM, resp.), attests a rather remarkable tolerance for bulk in this location.
引用
收藏
页码:692 / 704
页数:13
相关论文
共 41 条
  • [1] Aghajanian GK, 1999, NEUROPSYCHOPHARMACOL, V21, pS16
  • [2] STRUCTURE-ACTIVITY-RELATIONSHIPS IN PSYCHOTOMIMETIC PHENYLALKYLAMINES
    ALDOUS, FAB
    BARRASS, BC
    BREWSTER, K
    BUXTON, DA
    GREEN, DM
    PINDER, RM
    RICH, P
    SKEELS, M
    TUTT, KJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1974, 17 (10) : 1100 - 1111
  • [3] CORRELATION OF PSYCHOTOMIMETIC ACTIVITY OF PHENETHYLAMINES AND AMPHETAMINES WITH 1-OCTANOL-WATER PARTITION-COEFFICIENTS
    BARFKNECHT, CF
    NICHOLS, DE
    DUNN, WJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (02) : 208 - 210
  • [4] PSYCHOPHARMACOLOGICAL ACTIVITY OF RING-SUBSTITUTED AND SIDE CHAIN-SUBSTITUTED BETA-PHENETHYLAMINES
    BENINGTON, F
    MORIN, RD
    CLARK, LC
    FOX, RP
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1958, 23 (12) : 1979 - 1984
  • [5] MOLECULAR-BIOLOGY OF 5-HT RECEPTORS
    BOESS, FG
    MARTIN, IL
    [J]. NEUROPHARMACOLOGY, 1994, 33 (3-4) : 275 - 317
  • [6] Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists
    Braden, Michael R.
    Parrish, Jason C.
    Naylor, John C.
    Nichols, David E.
    [J]. MOLECULAR PHARMACOLOGY, 2006, 70 (06) : 1956 - 1964
  • [7] Translocation of the 5-alkoxy substituent of 2,5-dialkoxyarylalkylamines to the 6-position:: Effects on 5-HT2A/2C receptor affinity
    Chambers, JJ
    Kurrasch-Orbaugh, DM
    Nichols, DE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (15) : 1997 - 1999
  • [8] Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT2A/2C receptor agonists
    Chambers, JJ
    Kurrasch-Orbaugh, DM
    Parker, MA
    Nichols, DE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (06) : 1003 - 1010
  • [9] CHOUDHARY MS, 1992, MOL PHARMACOL, V42, P627
  • [10] CHOUDHARY MS, 1993, MOL PHARMACOL, V43, P755